| Mary Agnes Johnson, NP | |
|
1400 8th Ave, Fort Worth, TX 76104-4110 | |
| (817) 922-7070 | |
| Not Available |
| Full Name | Mary Agnes Johnson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1400 8th Ave, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003251539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 834891 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jps Health Network | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrative Emergency Services Physician Group Pa | 0749447936 | 57 |
News Archive
Orlando Health will soon begin providing a new therapy that allows oncologists to see the tumor they are treating continuously during radiation therapy.
Astronauts on board Space Shuttle Discovery (STS-131) activated an experiment this morning as part of the ninth scientific payload for Astrogenetix, an Austin, Texas-based commercial biotech company. Astrogenetix is conducting the International Space Station National Laboratory Pathfinder Vaccine (NLP-V) missions to take advantage of the unique conditions of microgravity to uncover changes in bacteria that can be targeted to create new vaccines and therapeutics.
Through their joint venture, SimVentures, HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, and Laerdal Medical, a global leader in the provision of educational solutions for healthcare providers and educators, today announced the launch of SimCenter. The
Gordon Burns is the technical director and co-founder of ETS Laboratories, which runs specialist wine analysis labs based in the Napa Valley in California. The North American wine industry has quite a different story to tell than honey that was discussed in another interview when it comes to authenticity issues.
Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration for PSI-7977 for the treatment of chronic hepatitis C virus infection. PSI-7977 is an oral uridine nucleotide analog polymerase inhibitor of HCV. Pharmasset recently completed dosing in a 28 day Phase 2a trial to evaluate PSI-7977 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in treatment-naive patients chronically infected with HCV genotype 1.
› Verified 4 days ago
| Entity Name | Integrative Emergency Services Physician Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285922542 PECOS PAC ID: 0749447936 Enrollment ID: O20120130000932 |
News Archive
Orlando Health will soon begin providing a new therapy that allows oncologists to see the tumor they are treating continuously during radiation therapy.
Astronauts on board Space Shuttle Discovery (STS-131) activated an experiment this morning as part of the ninth scientific payload for Astrogenetix, an Austin, Texas-based commercial biotech company. Astrogenetix is conducting the International Space Station National Laboratory Pathfinder Vaccine (NLP-V) missions to take advantage of the unique conditions of microgravity to uncover changes in bacteria that can be targeted to create new vaccines and therapeutics.
Through their joint venture, SimVentures, HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, and Laerdal Medical, a global leader in the provision of educational solutions for healthcare providers and educators, today announced the launch of SimCenter. The
Gordon Burns is the technical director and co-founder of ETS Laboratories, which runs specialist wine analysis labs based in the Napa Valley in California. The North American wine industry has quite a different story to tell than honey that was discussed in another interview when it comes to authenticity issues.
Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration for PSI-7977 for the treatment of chronic hepatitis C virus infection. PSI-7977 is an oral uridine nucleotide analog polymerase inhibitor of HCV. Pharmasset recently completed dosing in a 28 day Phase 2a trial to evaluate PSI-7977 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in treatment-naive patients chronically infected with HCV genotype 1.
› Verified 4 days ago
| Entity Name | Acclaim Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780076562 PECOS PAC ID: 4587963582 Enrollment ID: O20160426000707 |
News Archive
Orlando Health will soon begin providing a new therapy that allows oncologists to see the tumor they are treating continuously during radiation therapy.
Astronauts on board Space Shuttle Discovery (STS-131) activated an experiment this morning as part of the ninth scientific payload for Astrogenetix, an Austin, Texas-based commercial biotech company. Astrogenetix is conducting the International Space Station National Laboratory Pathfinder Vaccine (NLP-V) missions to take advantage of the unique conditions of microgravity to uncover changes in bacteria that can be targeted to create new vaccines and therapeutics.
Through their joint venture, SimVentures, HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, and Laerdal Medical, a global leader in the provision of educational solutions for healthcare providers and educators, today announced the launch of SimCenter. The
Gordon Burns is the technical director and co-founder of ETS Laboratories, which runs specialist wine analysis labs based in the Napa Valley in California. The North American wine industry has quite a different story to tell than honey that was discussed in another interview when it comes to authenticity issues.
Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration for PSI-7977 for the treatment of chronic hepatitis C virus infection. PSI-7977 is an oral uridine nucleotide analog polymerase inhibitor of HCV. Pharmasset recently completed dosing in a 28 day Phase 2a trial to evaluate PSI-7977 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in treatment-naive patients chronically infected with HCV genotype 1.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Agnes Johnson, NP 2900 Willing Ave, Fort Worth, TX 76110-3446 Ph: (334) 744-0554 | Mary Agnes Johnson, NP 1400 8th Ave, Fort Worth, TX 76104-4110 Ph: (817) 922-7070 |
News Archive
Orlando Health will soon begin providing a new therapy that allows oncologists to see the tumor they are treating continuously during radiation therapy.
Astronauts on board Space Shuttle Discovery (STS-131) activated an experiment this morning as part of the ninth scientific payload for Astrogenetix, an Austin, Texas-based commercial biotech company. Astrogenetix is conducting the International Space Station National Laboratory Pathfinder Vaccine (NLP-V) missions to take advantage of the unique conditions of microgravity to uncover changes in bacteria that can be targeted to create new vaccines and therapeutics.
Through their joint venture, SimVentures, HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, and Laerdal Medical, a global leader in the provision of educational solutions for healthcare providers and educators, today announced the launch of SimCenter. The
Gordon Burns is the technical director and co-founder of ETS Laboratories, which runs specialist wine analysis labs based in the Napa Valley in California. The North American wine industry has quite a different story to tell than honey that was discussed in another interview when it comes to authenticity issues.
Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration for PSI-7977 for the treatment of chronic hepatitis C virus infection. PSI-7977 is an oral uridine nucleotide analog polymerase inhibitor of HCV. Pharmasset recently completed dosing in a 28 day Phase 2a trial to evaluate PSI-7977 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in treatment-naive patients chronically infected with HCV genotype 1.
› Verified 4 days ago
Mrs. Amy Michelle Medalie, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4405 River Oaks Blvd, Fort Worth, TX 76114 Phone: 817-624-1770 Fax: 817-625-1287 | |
Valerie Elise Ward, RN, CPNP-PC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2755 Miller Ave, Fort Worth, TX 76105 Phone: 817-534-7110 Fax: 817-413-0521 | |
Maria Sybil Gagliano, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6000 Bryant Irvin Rd, Fort Worth, TX 76132 Phone: 866-389-2727 | |
Kristi E Tucker, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 801 7th Ave, Fort Worth, TX 76104 Phone: 682-885-1475 Fax: 682-885-7520 | |
Lacy Pitchford, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1263 W Rosedale St Ste 200, Fort Worth, TX 76104 Phone: 817-336-4896 Fax: 817-332-2805 | |
Susan Akberzie, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1401 W Pulaski St, Fort Worth, TX 76104 Phone: 682-885-8012 Fax: 682-885-8014 |